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The effects of niacin and exercise on lipid and glucose metabolism are well documented 
in men and premenopausal women, however no studies have been conducted that 
looked at extended release niacin therapy and exercise in postmenopausal women. 
PURPOSE: To determine the effects of niacin and a single bout of aerobic exercise on 
glucose, insulin, and C-peptide profiles in sedentary postmenopausal women. 
METHODS: Seventeen sedentary, postmenopausal women (mean ± SD; 57 ± 7.5 
years; 160.1 ± 7 cm; 77.2 ± 14.8 kg, 47.0 ± 6.2 % body fat) served as participants. They 
were randomly assigned to the resting (R) or exercise (EX) without niacin (WON) trial 
followed by the with-niacin (WN) trial (1000 mg/day of Niaspan niacin for 4 weeks). The 
EX trial consisted of treadmill walking at 60% HRR until 400 kcal were expended. Blood 
samples were collected immediately before (0 hr), 24 hr and 48 hr post R and EX for 
each trial. Changes in glucose, insulin, and C-peptide were determined via a 2 x 2 
repeated measures analysis of variance (ANOVA) for each dependent variable and the 
Bonferroni adjustment served as the post hoc test. The level of statistical significance 
was set at p < .05. RESULTS: Only the 24 hr time point was used in this data analysis. 
Exercise alone or combined with niacin showed no significant change in values. The 
mean fasting values for glucose, insulin, and C-peptide all significantly increased 
between the WON and WN trials; glucose increased 10.6%, from 95.03 ± 10.67 mg/dL 
to 105.07 ± 13.56 mg/dL; insulin increased 61.8%, from 16.98 ± 12.49 µU/mL to 27.48 ± 
14.84 µU/mL; and C-peptide increased 46.1%, from 1.65 ± 0.75 ng/mL to 2.41 ± 0.97 
ng/mL. CONCLUSION: Although niacin was generally well tolerated by the participants, 
given its adverse effects on glucose, insulin, and C-peptide profiles, the use of niacin in 
postmenopausal women should be done so with caution and under medical supervision 
until further investigations consisting of niacin alone or with aerobic exercise for longer 
periods of time are conducted. 
